CD68- and CD163-positive tumor infiltrating macrophages in non-metastatic breast cancer: a retrospective study and meta-analysis.

Furthermore, our results indicated that high numbers of CD163-positive TAMs were associated with short 5-year overall survival ( P = 0.003, Figure 1 B); however, although there was a trend in which patients with a higher number of CD68-positive cells had poorer survival rates ( P = 0.063), the result did not reach statistical significance (Figure 1 A).

also in 111,027 other papers